Humoral and cellular immune responses to CoronaVac up to one year after vaccination

Coronavac is a widely used SARS-CoV-2 inactivated vaccine, but its long-term immune response assessment is still lacking. We evaluated SARS-CoV-2-specific immune responses, including T cell activation markers, antigen-specific cytokine production and antibody response following vaccination in 53 adu...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Priscilla Ramos, Correia, Carolina Argondizo, Marmorato, Mariana Prado, Dias, Juliana Zanatta de Carvalho, Thomazella, Mateus Vailant, Cabral da Silva, Amanda, de Oliveira, Ana Carolina Soares, Gusmão, Arianne Fagotti, Ferrari, Lilian, Freitas, Angela Carvalho, Patiño, Elizabeth González, Grifoni, Alba, Weiskopf, Daniela, Sette, Alessandro, Scharf, Rami, Kallás, Esper Georges, Silveira, Cássia Gisele Terrassani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634255/
https://www.ncbi.nlm.nih.gov/pubmed/36341425
http://dx.doi.org/10.3389/fimmu.2022.1032411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634255/
https://www.ncbi.nlm.nih.gov/pubmed/36341425
http://dx.doi.org/10.3389/fimmu.2022.1032411

Ejemplares similares